PRMT5 and neoplasm: This prompted us to hypothesize that the potent antitumor effect of PRMT5 knockdown observed in vivo might not be solely attributable to these direct, cell-intrinsic effects on tumor cells, but likely involves a critical additional component, such as modulation of the tumor immune microenvironment.